| CXCR4 cytoplasmic expression | CXCR4 nuclear expression | CCR7 expression | EGFR expression | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Low | High | P | Low | High | P | Low | High | P | Low | High | P |
 | (n) | (n) |  | (n) | (n) |  | (n) | (n) |  | (n) | (n) |  |
age | Â | Â | .842 | Â | Â | .409 | Â | Â | .169 | Â | Â | .299 |
<50 | 43 | 51 | Â | 38 | 56 | Â | 37 | 57 | Â | 49 | 45 | Â |
≥50 | 47 | 59 |  | 49 | 57 |  | 52 | 54 |  | 63 | 43 |  |
tumor size | Â | Â | .539 | Â | Â | .106 | Â | Â | .945 | Â | Â | .525 |
D≤2 | 27 | 41 |  | 36 | 32 |  | 31 | 37 |  | 38 | 30 |  |
2<D≤5 | 50 | 56 |  | 39 | 67 |  | 46 | 60 |  | 62 | 44 |  |
D>5 | 13 | 13 | Â | 12 | 14 | Â | 12 | 14 | Â | 12 | 14 | Â |
grade | Â | Â | .068 | Â | Â | .985 | Â | Â | .786 | Â | Â | .030* |
I | 6 | 8 | Â | 6 | 8 | Â | 6 | 8 | Â | 9 | 5 | Â |
II | 59 | 73 | Â | 58 | 74 | Â | 61 | 71 | Â | 81 | 51 | Â |
III | 25 | 29 | Â | 23 | 31 | Â | 22 | 32 | Â | 22 | 32 | Â |
stage | Â | Â | .148 | Â | Â | .052 | Â | Â | .086 | Â | Â | .088 |
I | 22 | 17 | Â | 23 | 16 | Â | 23 | 16 | Â | 22 | 17 | Â |
II | 61 | 77 | Â | 58 | 80 | Â | 60 | 78 | Â | 82 | 56 | Â |
III | 7 | 13 | Â | 6 | 14 | Â | 5 | 15 | Â | 8 | 12 | Â |
IV | 0 | 3 | Â | 0 | 3 | Â | 1 | 2 | Â | 0 | 3 | Â |
LN | Â | Â | <.001** | Â | Â | .199 | Â | Â | <.001** | Â | Â | .046* |
negative | 59 | 41 | Â | 48 | 52 | Â | 59 | 41 | Â | 63 | 37 | Â |
positive | 31 | 69 | Â | 39 | 61 | Â | 30 | 70 | Â | 49 | 51 | Â |
N | Â | Â | .437 | Â | Â | .534 | Â | Â | .341 | Â | Â | .770 |
N≤3 | 11 | 30 |  | 18 | 23 |  | 10 | 31 |  | 21 | 20 |  |
3<N≤10 | 11 | 16 |  | 11 | 16 |  | 11 | 16 |  | 14 | 13 |  |
N>10 | 9 | 23 | Â | 10 | 22 | Â | 9 | 23 | Â | 14 | 18 | Â |
ER | Â | Â | .256 | Â | Â | .117 | Â | Â | .319 | Â | Â | .087 |
negative | 49 | 51 | Â | 49 | 51 | Â | 48 | 52 | Â | 50 | 50 | Â |
positive | 41 | 59 | Â | 38 | 62 | Â | 41 | 59 | Â | 62 | 38 | Â |
PR | Â | Â | .115 | Â | Â | .084 | Â | Â | .249 | Â | Â | .466 |
negative | 51 | 50 | Â | 50 | 51 | Â | 49 | 52 | Â | 54 | 47 | Â |
positive | 39 | 60 | Â | 37 | 62 | Â | 40 | 59 | Â | 58 | 41 | Â |
HER2/neu | Â | Â | .039* | Â | Â | .852 | Â | Â | .099 | Â | Â | .005** |
negative | 75 | 78 | Â | 66 | 26 | Â | 73 | 80 | Â | 94 | 59 | Â |
positive | 15 | 32 | Â | 21 | 87 | Â | 16 | 31 | Â | 18 | 29 | Â |